Please provide your email address to receive an email when new articles are posted on . Chemotherapy-induced peripheral neuropathy is a potentially debilitating, often persistent adverse event ...
University Orthopedics’ East Bay Surgery Center in East Providence, R.I., has become the first site in the state to implant a closed-loop spinal cord stimulator. Shiqiang “Chris” Tian, MD, an ...
Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. (HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly ...
“In the adjuvant setting, where patients feel there is a better likelihood of survival, patients are likely to downplay side effects… In the end-stage setting, a patient is more likely to report pain ...
SOUTH BEND, Ind. (WNDU) - November is National Diabetes Awareness Month! 37,000,000 Americans have diabetes - a condition where your body doesn’t make insulin, or doesn’t use it well. 50 to 70 percent ...
Mehmet Emin Yilmaz, MD, Ali Kemal Kadiroglu, MD, Ismail Hamdi Kara, MD, Suber Dikici, MD After 5 days, the patient's symptoms resolved and the pain was relieved. The pain was reevaluated by VAS and ...
(MENAFN- GlobeNewsWire - Nasdaq) Renowned pain management and medical technology leader to accelerate Glucotrack's strategy for integrated glucose monitoring applications, building on Company's 2024 ...
Statin drugs can increase the risk of developing peripheral neuropathy, according to a study published in the May 14 issue of Neurology, the scientific journal of the American Academy of Neurology. St ...
RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback